Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 1, 1998, Pages 37-42

  Pai, Howard H ^a   Rochon, Louise ^a   Clark, Brenda ^a   Black, Martin ^a   Shenouda, George ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Carcinoma; Glottis; p53 Protein; Radiotherapy

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; FEMALE; GENE OVEREXPRESSION; GLOTTIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032053659     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00025-X     Document Type: Article

References (27)

1. Sessions R. B., Harrison L. B., Hong W. K. Tumors of the larynx and hypopharynx. Devita V. T., Hellman S., Rosenburg S. A. Cancer principles & practice of oncology. 1993;631-655 Lippincott Co, Philadelphia, PA.
2. Fein D. A., Lee W. A., Hanlon A. L., Ridge J. A., Curran W. J., Coia L. R. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinoma of the glottic larynx. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;823-831.
3. Rudoltz M. S., Benammar A., Mohihuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;767-772.
4. Schwaibold F., Scariato A., Nunno M., Wallner P. E., Lustig R. A., Rouby E., Gorshein D., Wenger J. The effect of fraction size on control of early-stage glottic cancer. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;451-454.
5. Wang C. C., Efird J. T. Does prolonged treatment course adversely affect local control or carcinoma of the larynx? Int. J. Radiat. Oncol. Biol. Phys. 29:1994;657-660.
6. Yu E., Shenouda G., Beaudet M., Black M. J. The impact of radiation therapy fraction size on local control of early glottic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;587-591.
7. Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L., Wyllie A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
8. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
9. Kaplan E. L., Meier P. Nonparametric estimations from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
10. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother. Rep. 50:1972;187-220.
11. Fisher R. A. Statistical methods for research workers. 1934;Edinburgh University, Edinburgh, UK.
12. Esrig D., Elmajian D., Groshen S., Freeman J. A., Stein J., Chen S-C., Nichols P. W., Skinner D. G., Jones P. A., Cote R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med. 331:1994;1259-1264.
13. Grignon D., Caplan R., Sarkar F., Lawton C. A., Hammond E. H., Pilepich M. V., Forman J., Mesic J., Fu K. K., Abrams R., Pajak T. F., Shipley W. U., Cox J. D. p53 status and prognosis of locally advanced prostate adenocarcinoma a study based on RTOG 86-10 . J. Nat. Cancer Inst. 89:1997;158-162.
14. Zeng Z-S., Sarkis A. S., Zhang Z-F., Klimstra D. S., Charytonowicz E., Guillem J. G., Cordon-Cardo C., Cohen A. M. P53 nuclear over-expression an independent predictor of survival in lymph node-positive colorectal cancer patients . J. Clin. Oncol. 12:1994;2043-2050.
15. Brennan J. A., Mao L., Hruban R. H., Boyle J. O., Eby Y. J., Koch W. M., Goodman S. N., Sidransky D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332:1995;429-435.
16. Bristow R. G. Checks and balances cell-cycle control and radiation oncology. Ciba-Geigy Bench-to-Bedside Series . 1995;82-88 Ciba-Geigy.
17. Cox L., Lane D. P. Tumour suppressors, kinases and clamps how p53 regulates the cell cycle progression in response to DNA damage . Bioessays. 17:1995;501-508.
18. Dulic V., Kaufman W., Wlim S., Tlsty T., Lees E., Harper J. W., Elledge S. J., Reed S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
19. Slevin N. J., Vasanthan S., Dougal M. Relative clinical influence of tumor dose vs. dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 25:1992;23-28.
20. Field J. K., Pavelic Z. P., Spandidos D. A., Stambrook P. J., Jones A. S., Gluckman J. L. The role of p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 119:1993;1118-1122.
21. Nadal A., Campo E., Pinto J., Mallofre C., Palacin A., Arias C., Traserra J., Cardesa A. P53 expression in normal dysplastic and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J. Pathol. 175:1995;181-188.
22. Dolcetti R., Doglioni C., Maestro R., Gasparotto D., Barzan L., Pastore A., Romanelli M., Boiocchi M. P53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx genetic and prognostic implications . Int. J. Cancer. 52:1992;179-182.
23. Dursun G., Sak S. D., Akyol G., Dursun A., Erekul S., Demireller A., Akiner M. Overexpression of p53 in laryngeal carcinoma clinicopathological implications . Ear Nose Throat J. 74:1995;645-648.
24. Awwad S., Jaros E., Somes J., Lunec J. P53 overexpression in head and neck carcinoma and radiotherapy results. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;323-332.
25. Spafford M. F., Koeppe J., Pan Z., Archer P. G., Meyers A. D., Franklin W. A. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 122:1996;627-632.
26. Salam M. A., Crocker J., Morris A. Over-expression of tumour suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic significance. Clin. Otolaryngol. 20:1995;49-52.
27. Bradford C. R., Zhu S., Wolf G. T., Poore J., Fisher S. G., Beals T., McClatchey K. D., Carey T. E. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol. Head Neck Surg. 113:1995;408-412.